Document is current
Any future updates will be listed below
-
Authors
Azzarà, Cecilia
Lombardi, Andrea
Gramegna, Andrea
Ori, Margherita
Gori, Andrea
Blasi, Francesco
Bandera, Alessandra
-
Funding
Funding for this research was provided by:
Università degli Studi di Milano
- License Information
-
More Information
Article History
Received: 14 March 2023
Accepted: 13 August 2023
First Online: 4 September 2023
Declarations
:
: Not applicable.
: The patient has provided informed consent to the publication of this case report.
: AL reports personal fees from Gilead Sciences Inc. and Isnmed Italy. AGr reports personal fees from Grifols, Chiesi, GSK, Vertex and Insmed Italy. MO reports personal fees from Grifols. FB reports grants and personal fees from AstraZeneca, grants and personal fees from Chiesi, personal fees from Grifols, grants and personal fees from GSK, personal fees from Guidotti, personal fees from Insmed, grants and personal fees from Menarini, personal fees from Novartis, personal fee from OM pharma, personal fees from Pfizer personal fees, personal fees from Janssen, personal fees from Vertex, personal fees from Viatris, personal fees from Zambon, in the last three years outside the submitted work. All the other authors have nothing to declare.
